Prior studies have shown both the precancer MCF10.AT1 cells and DCIS cells to harbor same pathway activating mutations (H-Ras that activates MEK pathway and PIK3CA that activates AKT pathway)8,17,18. This evidence concerns the gene PIK3CA and ductal breast carcinoma in situ.